Jennifer Hudson, Earth, Wind & Fire and Jermaine Paul to perform at Premier Event Raising Urgent Funds for Cancer Research
NORWALK, Conn.--(BUSINESS WIRE)-- The Multiple Myeloma Research Foundation (MMRF) announced today that Jennifer Hudson, Earth, Wind & Fire and Jermaine Paul will be the featured performers at a tribute concert celebrating Clive J. Davis at the 15th Anniversary of the MMRF Fall Gala, to be held October 27, 2012, in Old Greenwich, Connecticut. The MMRF will be honoring the five-time Grammy Award winner and noted music industry executive Davis with the MMRF Spirit of Hope Award, presented annually to individuals who inspire hope with their perseverance in overcoming personal obstacles. All funds raised will support the development of life-extending treatments for multiple myeloma, an incurable blood cancer.
Jennifer Hudson to perform at 15th Anniversary of the Multiple Myeloma Research Foundation (MMRF) Fall Gala
An Academy Award-winning actress, Grammy Award-winning recording artist, best-selling author and clothing designer, Jennifer Hudson is an extraordinary talent. In 2004, she gained national acclaim as a contestant on the third season of American Idol. Hudson made her award-winning film debut in the 2006 production of Dreamgirls and her chart-topping music debut in 2008 with Arista Records, which was founded by Davis. Hudson became the national spokesperson for Weight Watchers in 2010.
Earth, Wind & Fire is one of the most innovative Pop and R&B music forces of the 20th century. The group was signed to Columbia Records in 1972 by Davis. With a career spanning over four decades, six Grammy Awards, eight #1 R&B singles, eight Double Platinum Top 10 Pop albums, and more than 90 million albums sold, VH1 ranked Earth, Wind & Fire as number 60 on their list of the 100 Greatest Artists of Rock & Roll.
Winner of the second season of NBC’s The Voice, Jermaine Paul is currently recording his debut album set for release at the top of December. Paul, a world renowned vocalist, previously sang background vocals for superstar Alicia Keys. Paul notably performed on Keys’ Grammy-Award winning album The Diary of Alicia Keys, which was released by Davis’ J Records and was nominated himself for a Grammy for a duet.
“I am proud to participate in this tribute concert for Clive Davis to benefit the MMRF – an organization that has helped so many patients and families affected by this devastating cancer,” said Hudson. “I hope my involvement will help the MMRF in their role of bringing new treatments and hope to cancer patients worldwide.”
The MMRF has been recognized as one of the nation’s most groundbreaking cancer research organizations. Significant MMRF achievements made possible by funding from programs like the MMRF Fall Gala include: opening more than 40 clinical trials with 21 novel treatments, sequencing the multiple myeloma genome, and helping to bring five new myeloma drugs to market in less than 10 years – including the July 2012 FDA approval of Onyx Pharmaceuticals, Inc.’s KyprolisTM, to which the MMRF provided pivotal support to advance its development. N. Anthony Coles, M.D., President and Chief Executive Officer of Onyx Pharmaceuticals will receive the MMRF Corporate Leadership Award at the gala.
Despite the advancements made by the MMRF, the five-year survival rate for myeloma remains one of the lowest of all cancers and multiple myeloma remains incurable. The funds raised by the MMRF are critical in continuing to advance research and the progress being made.
“We are so thankful to have Jennifer Hudson, Earth, Wind & Fire and Jermaine Paul joining the MMRF to help honor Clive Davis and support our urgent work,” said Kathy Giusti, Founder and CEO of the MMRF and a myeloma patient. “The endorsement of our mission by these talented musicians, who are joining us to celebrate this momentous event, is critical to raising awareness for this rare cancer.”
The MMRF Fall Gala is the largest benefit in Fairfield County and is attended by more than 1,200 people, including many celebrities and the nation’s most prominent business executives and high-impact philanthropists. It is anticipated that this event will be sold out. To reserve a table for the MMRF Fall Gala, donate an auction item or inquire about sponsorship opportunities, please email firstname.lastname@example.org or call 888-584-5463.
About the Multiple Myeloma Research Foundation (MMRF)
The Multiple Myeloma Research Foundation (MMRF) was established in 1998 as a 501(c)(3) non-profit organization by twin sisters Karen Andrews and Kathy Giusti, soon after Kathy's diagnosis with multiple myeloma. The mission of the MMRF is to relentlessly pursue innovative means that accelerate the development of next-generation multiple myeloma treatments to extend the lives of patients and lead to a cure. As the world's number-one private funder of multiple myeloma research, the MMRF has raised over $200 million since its inception and directs 90% of total budget to research and related programming. As a result, the MMRF has been awarded Charity Navigator’s coveted four four-star rating for nine consecutive years, the highest designation for outstanding fiscal responsibility and exceptional efficiency. For more information about the MMRF, please visit www.themmrf.org.
About Multiple Myeloma
Multiple myeloma is an incurable blood cancer. The five-year relative survival rate for multiple myeloma is approximately 38 percent, one of the lowest of all cancers. In 2012, more than 20,000 adults in the United States will be diagnosed with multiple myeloma and nearly 11,000 people are predicted to die from the disease.
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20121001006741/en/
Anne Quinn Young, 203-536-8691
Source: The Multiple Myeloma Research Foundation (MMRF)